News Focus
News Focus
Followers 24
Posts 1003
Boards Moderated 0
Alias Born 09/10/2013

Re: Chemdeps post# 70232

Sunday, 09/21/2014 7:01:51 PM

Sunday, September 21, 2014 7:01:51 PM

Post# of 405212
You're correct, Chemdeps...

The idea, per Leo, is to License B in order to fund K and P. What is unknown is whether the license will be for one indication, or the entire B platform. Value changes exponentially between the two.
I was directing my scorn towards the folks that are predicting a full buyout by next year.
No. That will not happen.
I will give some credence to the idea of a buyout MUCH further down the road, when the pipeline is flushed out more, but not before then.
Brilacidin, acquired for peanuts remember, is the Cellceutix equivalent of a "flip." It will free them from Aspire, while allowing for the continuation of other trials, and provide delicious revenue in the form of upfronts, milestones, and eventual royalties, and all within 2 years of the "heist."

Brilliant if you ask me. You didn't, but brilliant nonetheless.


"Kill your doubt, with the coldest of weapons, confidence."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y